Back to Search
LAWRENCE MULDOON, M.D.
M.D.
Urology Physician
NPI: 1598861528Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
030710(CT)
Research & Publications (20)
Efficacy and MRI of rituximab and methotrexate treatment in a nude rat model of CNS lymphoma.
PMID 19158414·Neuro Oncol·2009
7-preclinical
Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model.
PMID 19142191·J Cereb Blood Flow Metab·2009
4-observational
Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models.
PMID 19177203·Neoplasia·2009
7-preclinical
Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model.
PMID 18772353·Neuro Oncol·2009
7-preclinical
N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
PMID 18295688·J Vasc Interv Radiol·2008
6-review
Framework for primary care organizations: the importance of a structural domain.
PMID 18055502·Int J Qual Health Care·2008
8-other
siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli.
PMID 19081762·Cancer Ther·2008
8-other
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models.
PMID 17909806·Cancer Chemother Pharmacol·2008
7-preclinical
Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
PMID 18072268·Cancer·2008
3-trial
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
PMID 17538176·J Clin Oncol·2007
6-review
Characterization and magnetic resonance imaging of a rat model of human B-cell central nervous system lymphoma.
PMID 17438111·Clin Cancer Res·2007
7-preclinical
Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting.
PMID 16858513·J Neurooncol·2007
7-preclinical
In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging.
PMID 17898131·Am J Physiol Cell Physiol·2007
4-observational
Implications of the blood-brain barrier in primary central nervous system lymphoma.
PMID 17134113·Neurosurg Focus·2006
6-review
Models of primary care service delivery in Ontario: why such diversity?
PMID 17722757·Healthc Manage Forum·2006
6-review
Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
PMID 16314949·J Neurooncol·2006
4-observational
Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting.
PMID 16552023·AJNR Am J Neuroradiol·2006
8-other
Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
PMID 16086410·Pediatr Blood Cancer·2006
8-other
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.
PMID 16219835·AJNR Am J Neuroradiol·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 425 POST RD, 2ND FLOOR
FAIRFIELD, CT 06824 - Phone
- (203) 254-1576
Quick Facts
- NPI
- 1598861528
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile